Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan Oral vs. Intravenous in Elderly Patients With Relapsed Ovarian Cancer
NCT00170690Phase 3Completed
- Sponsor
- NOGGO
- Start
- Aug 2004
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of treosulfan in ovarian cancer (2 arms), sponsored by NOGGO. Primary endpoint: Patient Compliance. Started Aug 2004; status: completed.
02
Drugs
treosulfan
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00170690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170690.